Drug Topics
MARCH 18, 2025
The top reported barriers to providing buprenorphine included regulatory and administrative, operational and attitudinal, and patient-related challenges.
STAT
MARCH 18, 2025
Private equity firms are acquiring facilities that care for people with intellectual or developmental disabilities at an alarming rate, according to a new report released Tuesday. The care industry for this population has been historically owned and operated by nonprofits and faith-based institutions. However, between 2013 and 2023, private equity firms made over 1,000 acquisitions of disability and elder care providers — a likely undercount, according to the report published by the Priva
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PhRMA
MARCH 17, 2025
Half of every dollar spent on medicines goes to entities that don’t make medicine—like pharmacy benefit managers (PBMs) and insurers who are aggressively consolidating their control over health care and hospitals, clinics and for-profit pharmacies in the 340B markup program. As entities in the supply chain that don’t make medicine are increasingly using medicines to subsidize other parts of their business, patients and employers face increasing costs and barriers to accessing c
The Checkup by Singlecare
MARCH 18, 2025
Raspberries are vibrant, juicy, and somewhat tart berries known for their rich fiber and antioxidant content. The berries are plucked and enjoyed as a healthy snack or topping on oatmeal and yogurt. But did you know that the leaves of the raspberry plant ( Rubus idaeus ) may have health benefits, too? You may have heard of red raspberry leaf tea. It is a caffeine-free herbal tea made from the dried leaves of the fruit-bearing plant.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
MARCH 20, 2025
Panelists discuss how antibody-drug conjugates (ADCs) often show more diverse outcomes in real-world settings compared with clinical trials, with varying efficacy and adverse effect profiles. Key practical considerations for pharmacists include appropriate dosing based on patient factors, managing drug interactions, implementing premedication protocols to minimize adverse reactions, and providing comprehensive supportive care.
Pharma Marketing Network
MARCH 17, 2025
Introduction In todays competitive pharmaceutical landscape, marketing strategies must evolve to meet changing customer expectations. Are you still relying on traditional marketing tactics, or have you embraced a more dynamic, omnichannel marketing approach? With healthcare providers (HCPs) and patients engaging across multiple digital and offline touchpoints, pharma brands that fail to adapt risk losing valuable market share.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MARCH 18, 2025
When Ted Matthews came out of retirement in early 2023 to retake the helm of the rural Texas hospital where he’d started his health care career, it was something of a rescue mission. They were having bake sales to keep the place afloat. Staff were updating their resumes. At every board meeting, they’d decide which bills to pay. “It was the consensus that we were going to be that twenty-seventh rural hospital in Texas to close,” said Matthews, interim CEO of Anso
The Checkup by Singlecare
MARCH 14, 2025
If youre one of the 47 million Americans who take a medication to treat high cholesterol, you may have heard of pravastatin , a statin drug that is approved by the Food and Drug Administration (FDA) to lower bad cholesterol levels and help prevent heart disease. While pravastatin, also sold under the brand name Pravachol, does not directly cause weight gain, some people may notice slight changes in their weight after starting the medication.
Pharmacy Times
MARCH 20, 2025
Panelists note how medical professionals discuss menopause therapy, addressing symptoms, treatment options, safety concerns, adverse events, and personalized management strategies through patient-centered care. Professionals prioritize transparent communication, comprehensive risk assessment, and collaborative decision-making to ensure patient comfort and optimal management of menopausal transition.
Pharma Marketing Network
MARCH 19, 2025
Introduction Social media has become an essential tool for pharmaceutical marketing. However, simply posting content is not enough. To measure success and improve engagement, pharma marketing teams must focus on the right social media analytics. But which metrics truly matter? With increasing regulations, evolving digital trends, and shifting audience behaviors, pharma marketers need to analyze data that aligns with brand goals, compliance requirements, and engagement strategies.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
MARCH 14, 2025
These findings challenge the common assumption that older adults might struggle to use more advance medical devices.
STAT
MARCH 18, 2025
Sarepta Therapeutics said Tuesday that a 16-year-old boy died after receiving Elevidys, its gene therapy for Duchenne muscular dystrophy, the first known death linked to the treatment. The teenager suffered liver failure, a side effect that has been seen with other gene therapy treatments over the last two decades. Sarepta said in its statement that a recent cytomegalovirus infection could have also contributed to the patient’s death, putting him at heightened risk.
The FDA Law Blog
MARCH 18, 2025
By Sara W. Koblitz Integral to the careful balance Congress struck when passing the Hatch-Waxman Amendments, the patent term extension (PTE) is intended to restore patent life that was consumed during regulatory review of an FDA-regulated product. Even though the PTE provisions established in the Drug Price Competition and Patent Restoration Act are forty-plus years old, courts are still grappling with questions about how to best implement the Patent Term Extension.
PharmaVoice
MARCH 19, 2025
Chinese companies are involved in one-fifth of pharma’s clinical development programs, but trade wars and regulatory hurdles could stymie dealmaking.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Marketing Network
MARCH 19, 2025
Introduction In the highly regulated pharmaceutical industry, audience engagement is more than just a marketing goalit is a necessity for building trust with healthcare professionals (HCPs) and patients. But how can pharma brands create meaningful connections in a digital landscape crowded with content? Unlike traditional consumer marketing, pharma marketing requires a strategic approach that balances compliance, education, and innovation.
Drug Topics
MARCH 14, 2025
Additional data shows that an investigational drug, given every 4 months with Apretude, kept viral levels suppressed for patients who were already on stable treatment.
STAT
MARCH 18, 2025
Three years ago, Arbor Biotechnologies CEO Devyn Smith appeared at the J.P. Morgan Healthcare Conference and laid out a grand vision: With $215 million in new capital, the biotech would push forward CRISPR-based drugs for a series of liver and brain diseases, beginning by filing for a first trial in under two years. It was, suffice to say, bold.
European Pharmaceutical Review
MARCH 18, 2025
Novo Nordisk has regained full membership with the Association of the British Pharmaceutical Industry (ABPI), following suspension in 2023. This action resulted after the pharmaceutical company made serious breaches of the ABPI Code of Practice in 2021. The case was the eighth instance in the past four decades that the ABPIs board has issued this degree of sanction, the industry body highlighted upon announcing the news.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmaVoice
MARCH 18, 2025
Smaller biotechs are finding creative ways to fund R&D at a time when the traditional financing channels have become more constrictive.
Hospital Pharmacy Europe
MARCH 18, 2025
In an era of rapid healthcare evolution, clinical pharmacy is at a crossroads in Europe, facing both unprecedented opportunities and pressing challenges, and Dr Monika Lutters, ESCP president, is at the forefront of these developments. Here, speaking to Gerry Hughes, she shares her insights on current clinical pharmacy challenges around expansion and integration of hospital pharmacists, and the exciting trajectory this branch of pharmacy is set to undertake in the years ahead.
Drug Topics
MARCH 14, 2025
A new report from the American Economic Liberties Project presents the continued challenges pharmacies face since Congress failure to pass PBM reform at the end of 2024.
STAT
MARCH 20, 2025
Wholesale egg prices have dropped by more than 40% since late February, a decline that should soon translate into broader savings for consumers at grocery stores. This welcome respite has largely resulted from the lull in significant bird flu outbreaks in recent weeks, perhaps due to seasonal patterns in the virus’s transmission. North American flyways typically remain quiet in February as migratory birds have yet to start their journeys from their winter habitats.
The Checkup by Singlecare
MARCH 18, 2025
Tirzepatide and semaglutide have exploded in popularity over the past few years, primarily due to their weight loss benefits. Tirzepatide is the active ingredient in both Mounjaro and Zepbound , while semaglutide is the active ingredient in Ozempic , Wegovy , and Rybelsus (an oral medicine). These medications act like natural hormones in the body, regulating appetite and reducing food noise (intrusive thoughts about food that interfere with weight loss efforts).
PharmaVoice
MARCH 17, 2025
Even with Big Pharmas pouring billions into the space, the potential of radiopharmaceuticals remains largely untapped.
Hospital Pharmacy Europe
MARCH 18, 2025
Scotlands first cardiology consultant pharmacist has been appointed by NHS Golden Jubilee to provide professional leadership and mentorship and improve patient outcomes across the region. Paul Forsyth, who has 20 years experience working with cardiac patients, most recently as a heart failure pharmacist and lead pharmacist in clinical cardiology (primary care) at NHS Greater Glasgow and Clyde, will work across organisational boundaries to support cardiology lead pharmacists in the west of Scotla
Drug Topics
MARCH 17, 2025
Tirzepatide and semaglutide show long-term health care cost savings but, the high cost of the medications offset the savings.
STAT
MARCH 18, 2025
As a reformed hypochondriac, I’m extremely vulnerable to the allure of pharmaceutical ads. I self-referred for GLP-1s years ago after seeing advertisements, and even though I am a diabetic, what followed were horrific health outcomes: hospitalizations, extensive procedures, scans, MRIs, pancreatitis, anemia, and thousands in medical expenses.
The Checkup by Singlecare
MARCH 20, 2025
Eliquis (apixaban) and aspirin are both oral drugs that decrease blood clotting, but that is where their similarities end. They thin the blood by very different mechanisms and are used for different medical conditions. How effective one is versus the other depends on the condition being treated. And their side effects and costs are quite different. Well compare and contrast Eliquis and aspirin so you better understand why your healthcare provider may recommend one over the other.
Pharmacy Times
MARCH 18, 2025
Treatment with HTD1801 resulted in significant reductions in the hemoglobin A1c level and improved key cardiometabolic and liver parameters.
PharmaVoice
MARCH 20, 2025
The death of a 16-year-old boy evokes a lengthy battle to realize the benefit of cutting-edge gene therapy while also enduring tragic risk.
Drug Topics
MARCH 18, 2025
On both an individual and societal level, researchers explored how social, cultural, and ethnic determinants impact the treatment and management of obesity.
STAT
MARCH 20, 2025
NEW YORK — A former top federal health official is publicly warning Robert F. Kennedy Jr. that wavering on vaccines and slashing federal programs during a deadly measles outbreak could unleash the next public health disaster. “The federal government might pause, but the measles virus doesn’t pause. Bacteria and viruses don’t pause.
The Checkup by Singlecare
MARCH 18, 2025
For many people with pain or inflammation, healthcare providers often prescribe medications like diclofenac or naproxen. These drugs belong to a group called nonsteroidal anti-inflammatory drugs (NSAIDs). Diclofenac and naproxen may help reduce inflammation and relieve pain caused by conditions like arthritis, menstrual cramps, or migraines. While both medications can help people relieve pain and discomfort that interferes with daily activities, they may differ in various ways.
Expert insights. Personalized for you.
468 
Let's personalize your content